This topic contains a solution. Click here to go to the answer

Author Question: Which of the following neurotransmitters exerts an inhibitory effect on gastrointestinal motility? ... (Read 32 times)

LaDunn

  • Hero Member
  • *****
  • Posts: 526
Which of the following neurotransmitters exerts an inhibitory effect on gastrointestinal motility?
 a. Cholecystokinin
  b. Neuropeptide Y
  c. Somatostatin
  d. Serotonin

Question 2

Mr. M has been diagnosed with chronic kidney disease Stage 5, requiring dialysis. His initial chemistries panel indicates he has low sodium, chloride and calcium levels as well as high potassium and phosphorus levels. The physician has put him on a fluid restriction, a potassium restriction, and a phosphorus restriction.Which of the following is contributing to Mr. M's fluid imbalance?
 a. kidney disease
 b. liver disease
 c. aldosterone secretion exceeding production
  d. excessive thirst
 e. poor diet



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

JYan

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

c

Answer to Question 2

a




LaDunn

  • Member
  • Posts: 526
Reply 2 on: Aug 20, 2018
:D TYSM


TheNamesImani

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library